Inflammatory bowel disease and the eye

被引：53

作者：

Ghanchi, FD

Rembacken, BJ

机构：

[1] Bradford Royal Infirm, Bradford Teaching Hosp, Bradford BD9 6RJ, W Yorkshire, England

[2] Leeds Gen Infirm, Leeds, W Yorkshire, England

来源：

SURVEY OF OPHTHALMOLOGY | 2003年 / 48卷 / 06期

关键词：

bowel resection; Crohn's disease; immunosuppression; scleritis; steroids; ulcerative colitis; uveitis;

D O I：

10.1016/j.survophthal.2003.08.004

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Inflammatory bowel disease includes Crohn's disease and ulcerative colitis, and is characterized by chronic inflammation of the intestines. The advances in understanding of the inflammatory process have resulted in improved treatment of inflammatory bowel disease. The systemic complications of inflammatory bowel disease involve many organs, eyes included. The ophthalmic complications are usually of inflammatory origin. Some of these complications, like scleritis, may reflect overall disease activity. Treatment of intestinal inflammation-either medical or surgical-usually helps resolution of ophthalmic complications. This review describes recent developments in the diagnosis and management of the inflammatory bowel disease and its ophthalmic complications. (C) 2003 Elsevier Inc. All rights reserved.

引用

页码：663 / 676

页数：14

共 136 条

[11] American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12 [J].

Brant, SR ;

Fu, YF ;

Fields, CT ;

Baltazar, R ;

Ravenhill, G ;

Pickles, MR ;

Rohal, PM ;

Mann, J ;

Kirschner, BS ;

Jabs, EW ;

Bayless, TM ;

Hanauer, SB ;

Cho, JH .

GASTROENTEROLOGY, 1998, 115 (05) :1056-1061

[12] Risk and natural history of colonic neoplasia in patients with primacy sclerosing cholangitis and ulcerative colitis [J].

Brentnall, TA ;

Haggitt, RC ;

Rabinovitch, PS ;

Kimmey, MB ;

Bronner, MP ;

Levine, DS ;

Kowdley, KV ;

Stevens, AC ;

Crispin, DA ;

Emond, M ;

Rubin, CE .

GASTROENTEROLOGY, 1996, 110 (02) :331-338

[13]

*BRIT MED ASS ROYA, 2001, BRIT NAT FORM

[14] TRENDS IN INCIDENCE RATES OF ULCERATIVE-COLITIS AND CROHNS-DISEASE [J].

CALKINS, BM ;

LILIENFELD, AM ;

GARLAND, CF ;

MENDELOFF, AI .

DIGESTIVE DISEASES AND SCIENCES, 1984, 29 (10) :913-920

[15]

CAMFIELD PR, 1982, J PEDIATR-US, V101, P157

[16] Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables [J].

Camma, C ;

Giunta, M ;

Rosselli, M ;

Cottone, M .

GASTROENTEROLOGY, 1997, 113 (05) :1465-1473

[17] Oral budesonide is as effective as oral prednisolone in active Crohn's disease [J].

Campieri, M ;

Ferguson, A ;

Doe, W ;

Persson, T ;

Nilsson, LG ;

Malchow, H ;

Prantera, C ;

Mani, V ;

OMorain, C ;

Selby, W ;

Pallone, F ;

diPietralata, MM ;

Sjodahl, R ;

Florin, T ;

Smith, P ;

Bianchi, P ;

Lofberg, R ;

Rutgeerts, P ;

Smallwood, R ;

Lamers, HW ;

TasmanJones, C ;

Hunter, JO ;

Hodgson, H ;

Danielsson, A ;

Lee, FI ;

Piacitelli, G ;

Giovanni, S ;

Ellis, A ;

Weir, DG .

GUT, 1997, 41 (02) :209-214

[18] Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1q, 3q, and 4q:: Evidence for epistasis between 1p and IBD1 [J].

Cho, JH ;

Nicolae, DL ;

Gold, LH ;

Fields, CT ;

LaBuda, MC ;

Rohal, PM ;

Pickles, MR ;

Qin, L ;

Fu, YF ;

Mann, JS ;

Kirschner, BS ;

Jabs, EW ;

Weber, J ;

Hanauer, SB ;

Bayless, TM ;

Brant, SR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7502-7507

[19] IMMUNOMODULATORY AGENTS AND OTHER MEDICAL THERAPIES IN INFLAMMATORY BOWEL-DISEASE [J].

COHEN, RD ;

HANAUER, SB .

CURRENT OPINION IN GASTROENTEROLOGY, 1995, 11 (04) :321-330

[20]

COLES RS, 1984, OPTHALMOLOGY, V91, P172

← 1 2 3 4 5 6 7 8 9 10 →